Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pfenex Inc (NYSE MKT LLC:PFNX)

21.32
Delayed Data
As of Sep 02
 +0.28 / +1.33%
Today’s Change
6.19
Today|||52-Week Range
24.41
+196.94%
Year-to-Date
No recent news for Pfenex Inc.

Today’s Trading

Previous close21.04
Today’s open21.18
Day’s range19.90 - 21.32
Volume95,826
Average volume (3 months)164,342
Market cap$486.7M
Dividend yield--
Data as of 4:02pm ET, 09/02/2015

Growth & Valuation

Earnings growth (last year)-173.68%
Earnings growth (this year)-50.96%
Earnings growth (next 5 years)--
Revenue growth (last year)-10.66%
P/E ratioNM
Price/Sales6.37
Price/Book7.17

Competitors

 Today’s
change
Today’s
% change
AEGRAegerion Pharmaceuti...+0.91+5.29%
OVASOvaScience Inc+0.27+1.55%
FPRXFive Prime Therapeut...+1.50+8.24%
CYADCelyad SA+3.24+6.96%
Data as of 3:59pm ET, 09/02/2015

Financials

Next reporting dateNovember 12, 2015
EPS forecast (this quarter)-$0.46
Annual revenue (last year)$10.6M
Annual profit (last year)-$9.8M
Net profit margin-92.01%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Secretary &
Director
Bertrand C. Liang
Vice President-Research &
Operations
Henry W. Talbot
Corporate headquarters
San Diego, California

Forecasts

Partner Offers